HHSN261201400039C;SBIR TOPIC 326 DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS;PROJECT TITLE: TARGETING BREAST CANCER STEM CELLS WITH PG-101;CONTRACT PERFORMANCE PERIOD 09/12/2

Information

  • Research Project
  • 8947615
  • ApplicationId
    8947615
  • Core Project Number
    N43CO000000
  • Full Project Number
    261201400039C-0-0-1
  • Serial Number
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/18/2014 - 11 years ago
  • Project End Date
    6/17/2015 - 10 years ago
  • Program Officer Name
  • Budget Start Date
    -
  • Budget End Date
    -
  • Fiscal Year
    2014
  • Support Year
  • Suffix
  • Award Notice Date
    -
Organizations

HHSN261201400039C;SBIR TOPIC 326 DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS;PROJECT TITLE: TARGETING BREAST CANCER STEM CELLS WITH PG-101;CONTRACT PERFORMANCE PERIOD 09/12/2

Targeting Breast cancer stem cells with PG-101

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    N43
  • Administering IC
    CA
  • Application Type
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    224997
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:224997\
  • Funding Mechanism
    SBIR/STTR Contracts
  • Study Section
  • Study Section Name
  • Organization Name
    PAGANINI BIOPHARMA, INC.
  • Organization Department
  • Organization DUNS
    969467898
  • Organization City
    ENCINO
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    913163904
  • Organization District
    UNITED STATES